Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends

Area of Science:

• Cardiovascular Medicine
• Pathophysiology
• Endocrinology

Background:

• Atherosclerosis risk factors induce multifaceted responses impacting cardiovascular health.
• These responses include clinical signs of ischemia, metabolic alterations, and sympathetic nervous system activation.
• Endocrine factors, particularly in women, influence atherosclerosis development and presentation.

Purpose of the Study:

• To elucidate the complex physiological responses to atherosclerosis risk factors.
• To highlight the role of oxidative stress and specific risk factors like smoking and endothelial dysfunction.
• To explore the differential impact of atherosclerosis on various demographic groups, including pre- and post-menopausal women.

Main Methods:

• Review and synthesis of existing data on atherosclerosis pathophysiology.
• Analysis of clinical, metabolic, and sympathetic markers associated with atherosclerosis.
• Comparative assessment of atherosclerosis risk and response in different populations.

Main Results:

• Atherosclerosis triggers clinical (ischemia, heart failure), metabolic (oxygen transport, coagulation), and sympathetic (heart rate, blood pressure) changes.
• Oxidative stress significantly promotes atherosclerotic lesion development.
• Premenopausal women exhibit distinct atherogenic profiles compared to post-menopausal women and men.

Conclusions:

• Multiple factors, including smoking and endothelial dysfunction, significantly influence cardiovascular events.
• Atherosclerosis risk factors are etiologic in cardiovascular alterations, potentially leading to irreversible damage.
• Understanding these responses is crucial for managing cardiovascular disease risk.